Stock price fluctuations for ADDDF.US, representing Addex Therapeutics, are influenced by various factors. Clinical Trial Results: Positive or negative outcomes from Addex's clinical trials significantly impact investor confidence and subsequently, the stock price.

Regulatory Approvals: Approvals from regulatory bodies like the FDA for their drug candidates will likely drive the price upwards, while rejection can cause a decline.

Financial Performance: Addex's financial health, including cash reserves, revenue streams (if any), and burn rate, plays a role in investor perception and stock valuation.

Partnerships and Collaborations: Strategic partnerships with larger pharmaceutical companies can boost credibility and inject capital, positively affecting the stock.

Market Sentiment: Overall market trends and investor sentiment towards the biotech sector can influence ADDDF.US, even without specific news about the company.

Competition: Developments in competing drugs or therapies targeting similar conditions can impact the perceived market potential for Addex's products.

Intellectual Property: The strength and breadth of Addex's patent portfolio are crucial for long-term value and can influence investor decisions.

Management Team: Confidence in the leadership team's ability to execute the company's strategy is a factor in determining stock price.